XYZAL levocetirizine dihydrochloride 5 mg/mL oral drops bottle

Nchi: Australia

Lugha: Kiingereza

Chanzo: Department of Health (Therapeutic Goods Administration)

Viambatanisho vya kazi:

levocetirizine dihydrochloride, Quantity: 5 mg/mL

Inapatikana kutoka:

UCB Australia Pty Ltd T/A UCB Pharma Division of UCB Australia

INN (Jina la Kimataifa):

levocetirizine dihydrochloride

Dawa fomu:

Oral Liquid

Tungo:

Excipient Ingredients: purified water; propylene glycol; glycerol; acetic acid; saccharin sodium; methyl hydroxybenzoate; propyl hydroxybenzoate; sodium acetate

Njia ya uendeshaji:

Oral

Vitengo katika mfuko:

1 x 15mL bottle, 1 x 20mL bottle, 1 x 10 mL bottle

Dawa ya aina:

(S2) Pharmacy Medicine

Matibabu dalili:

Xyzal oral drops are indicated for the symptomatic treatment of allergic rhinitis (including persistent rhinitis) and chronic idiopathic urticaria in adults and children aged 2 years and over.

Bidhaa muhtasari:

Visual Identification: Clear, colourless solution; Container Type: Bottle; Container Life Time: 3 Years; Container Temperature: Store below 30 degrees Celsius; Container Closure: Child resistant closure

Idhini hali ya:

Registered

Idhini ya tarehe:

2010-01-19